8-KLeadership Changes

CrowdStrike Holdings, Inc. 8-K Report, Executive Changes (Dec 3, 2020)

Filed December 3, 2020For Securities:CRWD

Summary

CrowdStrike Holdings, Inc. announced a key addition to its Board of Directors on November 30, 2020, with the appointment of Laura J. Schumacher. This expansion increases the Board size to nine members and immediately positions Ms. Schumacher as a member of the Nominating and Corporate Governance Committee. Her appointment is effective until the 2022 annual stockholder meeting. Ms. Schumacher brings a wealth of experience, particularly in legal and external affairs, from her extensive career at AbbVie, Inc., where she currently serves as Vice Chairman, External Affairs and Chief Legal Officer. Her background also includes significant roles at Abbott Laboratories. The company has confirmed that Ms. Schumacher meets Nasdaq's independence standards, which is a positive signal for strong corporate governance. Investors should view this as an enhancement to the board's expertise, particularly in areas critical for a publicly traded technology company.

Key Highlights

  • 1Appointment of Laura J. Schumacher to the Board of Directors.
  • 2Board size increased from eight to nine directors.
  • 3Ms. Schumacher appointed to the Nominating and Corporate Governance Committee.
  • 4Ms. Schumacher has extensive legal and external affairs experience from AbbVie and Abbott Laboratories.
  • 5Ms. Schumacher is considered independent under Nasdaq standards.
  • 6Ms. Schumacher's term extends until the 2022 annual stockholder meeting.
  • 7No disclosed arrangements, understandings, family relationships, or related party transactions concerning Ms. Schumacher's appointment.

Frequently Asked Questions

Laura J. Schumacher is a new member of CrowdStrike's Board of Directors. She has a strong background in legal and external affairs, currently serving as Vice Chairman, External Affairs and Chief Legal Officer at AbbVie, Inc. Prior to that, she held senior legal positions at AbbVie and Abbott Laboratories. She also serves on the board of General Dynamics Corporation.

Ms. Schumacher's appointment is significant because it adds experienced leadership to the Board, particularly in legal and corporate governance matters. Her independence and extensive executive experience from a major public company like AbbVie enhance the Board's oversight capabilities and strategic guidance for CrowdStrike.

Yes, the Company has determined that Ms. Schumacher is independent within the meaning of Nasdaq's standards of independence for directors. This is an important factor for good corporate governance.

Ms. Schumacher will receive compensation for her service as a director in accordance with CrowdStrike's Outside Director Compensation Policy, as detailed in the company's proxy statement filed on May 22, 2020.